Dexomart-60 Capsules

Dexomart-60 Dexlansoprazole 60 mg Modified-Release Capsules

Dexomart-60 is a modified-release oral capsule formulation containing Dexlansoprazole 60 mg as modified-release pellets. Dexlansoprazole belongs to the proton pump inhibitor (PPI) class and works by reducing gastric acid secretion.

Composition

Dexlansoprazole 60 mg
(As modified release pellets)

Therapeutic Class

Antiulcerant

Pharmacological Class

Proton Pump Inhibitor (PPI)

Uses

Dexomart-60 may be prescribed for:

• Erosive esophagitis
• Healing of acid-related damage to the esophagus
• Maintenance of healed erosive esophagitis where clinically appropriate
• Symptomatic gastroesophageal reflux disease (GERD)
• Other acid-related gastrointestinal conditions as directed by a healthcare professional

How It Works

Dexlansoprazole is a proton pump inhibitor that suppresses gastric acid secretion by inhibiting the H+/K+-ATPase proton pump in gastric parietal cells. The modified-release formulation provides controlled release of the active ingredient.

Key Product Features

• Contains Dexlansoprazole 60 mg
• Modified-release pellet formulation
• Proton pump inhibitor
• Oral capsule dosage form
• Designed for management of acid-related gastrointestinal conditions

Product Information

Brand Name: Dexomart-60

Composition: Dexlansoprazole 60 mg

Dosage Form: Modified-Release Capsules

Route of Administration: Oral

Therapeutic Class: Antiulcerant

Pharmacological Class: Proton Pump Inhibitor (PPI)

Pack Size: 10 x 10 Capsules

Directions for Use

Take Dexomart-60 exactly as prescribed by a qualified healthcare professional.

The capsule should be swallowed whole. Do not crush or chew the modified-release pellets unless specifically instructed by a healthcare professional.

The dose and duration of treatment depend on the clinical condition and physician's recommendation.

Important Information

Dexomart-60 is a prescription medicine and should be used under medical supervision.

Inform your healthcare professional about existing medical conditions, allergies and other medicines being taken before starting treatment.

Long-term or inappropriate use of acid-suppressing medicines should be undertaken only under appropriate medical guidance.

Storage

Store protected from light and moisture at a temperature not exceeding 30°C, as indicated on the product packaging.

Keep the medicine out of reach of children.

Product Summary

Dexomart-60 contains Dexlansoprazole 60 mg in a modified-release capsule formulation. As a proton pump inhibitor, it reduces gastric acid secretion and is used under medical supervision for acid-related gastrointestinal conditions, including erosive esophagitis and GERD.